# Good Gaming, Inc.: financial statements, quarterly

GMER · OTC · CIK 1454742 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gmer.md) · [Financials](/companies/gmer/financials.md) · [Filings](/companies/gmer/filings.md) · [Insiders](/companies/gmer/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gmer/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [0.0](/filings/0001493152-24-045681.md) | [0.0 d](/filings/0001641172-25-001868.md) | [0.2](/filings/0001641172-25-010826.md) | [0.2](/filings/0001641172-25-023550.md) | [0.2](/filings/0001493152-25-023350.md) | [(0.1) d](/filings/0001493152-26-015189.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Cost of revenue | $k | [44.4](/filings/0001493152-24-045681.md) | [43.5 d](/filings/0001493152-24-012092.md) | [72.4](/filings/0001641172-25-010826.md) | [76.5](/filings/0001641172-25-023550.md) | [18.9](/filings/0001493152-25-023350.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $k | [(44.4)](/filings/0001493152-24-045681.md) | [250 d](/filings/0001641172-25-001868.md) | [(72.2)](/filings/0001641172-25-010826.md) | [(76.3)](/filings/0001641172-25-023550.md) | [(18.7)](/filings/0001493152-25-023350.md) | [168 d](/filings/0001493152-26-015189.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [(276)](/filings/0001493152-24-045681.md) | [(1.0) d](/filings/0001641172-25-001868.md) | [(355)](/filings/0001641172-25-010826.md) | [(326)](/filings/0001641172-25-023550.md) | [(191)](/filings/0001493152-25-023350.md) | [(77.8) d](/filings/0001493152-26-015189.md) | [(80.0)](/filings/0001493152-26-023599.md) | [(52.3)](/filings/0001493152-26-036570.md) | [(49.7)](/filings/0001493152-25-023350.md) | [(49.9) d](/filings/0001493152-26-015189.md) | [(61.8)](/filings/0001493152-26-023599.md) | [(43.8)](/filings/0001493152-26-036570.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | [1.0](/filings/0001493152-26-023599.md) | [1.0](/filings/0001493152-26-036570.md) | [1.0](/filings/0001493152-25-023350.md) | [0.8 d](/filings/0001493152-26-015189.md) | [1.2](/filings/0001493152-26-023599.md) | [1.2](/filings/0001493152-26-036570.md) |
| Net income | $k | [(276)](/filings/0001493152-24-045681.md) | [118 d](/filings/0001641172-25-001868.md) | [(355)](/filings/0001493152-25-023350.md) | [(320)](/filings/0001493152-25-023350.md) | [(178)](/filings/0001493152-25-023350.md) | [(110) d](/filings/0001493152-26-015189.md) | [(81.0)](/filings/0001493152-26-036570.md) | [(53.3)](/filings/0001493152-26-036570.md) | [(50.7)](/filings/0001493152-25-023350.md) | [104 d](/filings/0001493152-26-023599.md) | [(63.0)](/filings/0001493152-26-036570.md) | [(45.0)](/filings/0001493152-26-036570.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.00](/filings/0001641172-25-010826.md) | [0.00](/filings/0001641172-25-023550.md) | [0.00](/filings/0001493152-25-023350.md) | not reported | [0.00](/filings/0001493152-26-023599.md) | [0.00](/filings/0001493152-26-036570.md) | [0.00](/filings/0001493152-25-023350.md) | not reported | [0.00](/filings/0001493152-26-023599.md) | [0.00](/filings/0001493152-26-036570.md) |
| Basic EPS | $ per share | not reported | not reported | [0.00](/filings/0001641172-25-010826.md) | [0.00](/filings/0001641172-25-023550.md) | [0.00](/filings/0001493152-25-023350.md) | not reported | [0.00](/filings/0001493152-26-023599.md) | [0.00](/filings/0001493152-26-036570.md) | [0.00](/filings/0001493152-25-023350.md) | not reported | [0.00](/filings/0001493152-26-023599.md) | [0.00](/filings/0001493152-26-036570.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $k | [223](/filings/0001493152-23-040846.md) | [304](/filings/0001641172-25-001868.md) | [158](/filings/0001493152-24-020107.md) | [34.0](/filings/0001493152-24-032705.md) | [8.3](/filings/0001493152-24-045681.md) | [14.5](/filings/0001493152-26-015189.md) | [2.2](/filings/0001641172-25-010826.md) | [5.4](/filings/0001641172-25-023550.md) | [22.8](/filings/0001493152-25-023350.md) | [13.5](/filings/0001493152-26-036570.md) | [24.8](/filings/0001493152-26-023599.md) | [25.0](/filings/0001493152-26-036570.md) |
| Current assets | $k | [237](/filings/0001493152-23-040846.md) | [398](/filings/0001641172-25-001868.md) | [223](/filings/0001493152-24-020107.md) | [70.1](/filings/0001493152-24-032705.md) | [31.1](/filings/0001493152-24-045681.md) | [91.9](/filings/0001493152-26-015189.md) | [55.5](/filings/0001641172-25-010826.md) | [34.8](/filings/0001641172-25-023550.md) | [44.2](/filings/0001493152-25-023350.md) | [91.1](/filings/0001493152-26-036570.md) | [78.3](/filings/0001493152-26-023599.md) | [54.5](/filings/0001493152-26-036570.md) |
| Total assets | $k | [352](/filings/0001493152-23-040846.md) | [484](/filings/0001641172-25-001868.md) | [333](/filings/0001493152-24-020107.md) | [180](/filings/0001493152-24-032705.md) | [125](/filings/0001493152-24-045681.md) | [91.9](/filings/0001493152-26-015189.md) | not reported | not reported | not reported | [91.1](/filings/0001493152-26-015189.md) | not reported | not reported |
| Current liabilities | $k | [531](/filings/0001493152-23-040846.md) | [520](/filings/0001641172-25-001868.md) | [716](/filings/0001493152-24-020107.md) | [814](/filings/0001493152-24-032705.md) | [918](/filings/0001493152-24-045681.md) | [978](/filings/0001493152-26-015189.md) | [1,009](/filings/0001641172-25-010826.md) | [1,041](/filings/0001641172-25-023550.md) | [1,101](/filings/0001493152-25-023350.md) | [1,199](/filings/0001493152-26-036570.md) | [1,249](/filings/0001493152-26-023599.md) | [1,270](/filings/0001493152-26-036570.md) |
| Total liabilities | $k | [531](/filings/0001493152-23-040846.md) | [520](/filings/0001641172-25-001868.md) | [716](/filings/0001493152-24-020107.md) | [814](/filings/0001493152-24-032705.md) | [918](/filings/0001493152-24-045681.md) | [978](/filings/0001493152-26-015189.md) | not reported | not reported | not reported | [1,199](/filings/0001493152-26-015189.md) | not reported | not reported |
| Long-term debt | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $k | [(179)](/filings/0001493152-24-045681.md) | [(35.9)](/filings/0001493152-26-015189.md) | [(383)](/filings/0001493152-25-023350.md) | [(635)](/filings/0001493152-25-023350.md) | [(792)](/filings/0001493152-25-023350.md) | [(886)](/filings/0001493152-26-036570.md) | [(953)](/filings/0001493152-26-036570.md) | [(1,006)](/filings/0001493152-26-036570.md) | [(1,057)](/filings/0001493152-25-023350.md) | [(1,108)](/filings/0001493152-26-036570.md) | [(1,171)](/filings/0001493152-26-036570.md) | [(1,216)](/filings/0001493152-26-036570.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(73.4) d](/filings/0001493152-24-045681.md) | [(69.8) d](/filings/0001641172-25-001868.md) | [(120)](/filings/0001641172-25-010826.md) | [(128) d](/filings/0001641172-25-023550.md) | [(31.4) d](/filings/0001493152-25-023350.md) | [(1.9) d](/filings/0001493152-26-015189.md) | [(12.3)](/filings/0001493152-26-023599.md) | [3.2 d](/filings/0001493152-26-036570.md) | [17.4 d](/filings/0001493152-25-023350.md) | [(9.3) d](/filings/0001493152-26-015189.md) | [11.3](/filings/0001493152-26-023599.md) | [0.2 d](/filings/0001493152-26-036570.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [109](/filings/0001493152-23-040846.md) | [113](/filings/0001493152-24-020107.md) | [115](/filings/0001493152-24-032705.md) | [115](/filings/0001493152-24-045681.md) | [121](/filings/0001641172-25-010826.md) | [124](/filings/0001641172-25-023550.md) | [126](/filings/0001493152-25-023350.md) | [129](/filings/0001493152-26-023599.md) | [129](/filings/0001493152-26-036570.md) | [129](/filings/0001493152-25-023350.md) | [129](/filings/0001493152-26-023599.md) | [129](/filings/0001493152-26-036570.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 129,117,273 at 2026-08-15, from the cover of the [10-Q filed 2026-08-07](/filings/0001493152-26-036570.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.